Next TARGET 9/11: Kill the Mosquitoes in Your life: Part II : WHO Facts about the Malaria

Today is 9/11 . 11 September 2011 was a black day of the history of mankind. People have always reason for whatever they do .When you ask a priest he will give his own justification for all the religious rituals. When you are any extremists they have their own reasons for that. I am not here to decide what is bad and what is good .But I just want to create a awareness about the deadliest beast not for the mankind also for the animal kingdom. According to World health organization half of the world is in its clutches. Is does not follow any religion, it does not afraid of any army, it can’t be hanged to death. I am talking about Mosquitoes.

In this series, I will provide some insight of the actual and philosophical mosquitoes in your life.

WHO Facts about the malaria

  • World Malaria Day was celebrated on 25 April 2013 by WHO
  • About 3.3 billion people – half of the world’s population – are at risk of malaria
  • According to the estimates, released in December 2013, there were about 207 million cases of malaria in 2012 (with an uncertainty range of 135 million to 287 million) and an estimated 627 000 deaths (with an uncertainty range of 473 to 789 million).
  • In areas with high transmission of malaria, children under 5 are particularly susceptible to infection, illness and death. More than two thirds (70%) of all malaria deaths occur in this age group. In 2015, about 305 000 African children died before their fifth birthdays.
  • Increased malaria prevention and control measures are dramatically reducing the malaria burden in many places. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under 5
  • Early diagnosis and treatment of malaria reduces disease and prevents deaths. It also contributes to reducing malaria transmission. Access to diagnostic testing and treatment should be seen not only as a component of malaria control but as a fundamental right of all populations at risk
  • Parasite resistance to artemisinin, the core compound in WHO-recommended combination treatments for uncomplicated malaria, has been detected in 5 countries of south east Asia: Cambodia, Laos, Myanmar, Thailand and Viet Nam. However, artemisinin-based combination therapies remain effective in almost all settings, as long as the partner drug in the combination is locally effective
  • Long-lasting insecticidal nets provide personal protection against mosquito bites. They can be used as protection for people most at risk of malaria, such as young children and pregnant women in high malaria transmission areas. The nets are effective for 2-3 years, depending on the model and conditions of use. Between 2000 and 2015, the proportion of children sleeping under an insecticide-treated net in sub-Saharan Africa increased from less than 2% to approximately 68%
  • The full potential of indoor residual spraying is obtained when at least 80% of houses in targeted areas are sprayed. Indoor spraying with insecticides kills the mosquito vector and is effective for 3–6 months, depending on the insecticide used and the type of surface on which it is sprayed. Longer-lasting forms of insecticides are under development
  • Pregnant women are at high risk of dying from the complications of severe malaria. Malaria is also a cause of spontaneous abortion, premature delivery, stillbirth and severe maternal anemia, and is responsible for about one third of preventable low-birth-weight babies. For pregnant women living in moderate-to-high transmission areas, WHO recommends intermittent preventive treatment at each scheduled antenatal visit after the first trimester.
  • In high-burden settings, malaria can trap families and communities in a downward spiral of poverty, disproportionately affecting marginalized and poor people who cannot afford treatment or who have limited access to health care
  • WHO recommends that oral artemisinin based mono therapies be withdrawn from the market and that marketing of these therapies should cease. Out of 24 pharmaceutical companies, half located in India, continued to market oral artemisinin mono therapies.
  • About 80% of estimated malaria cases in 2013 occurred in just18 countries and 80% of deaths in 16 countries. Three countries (India, Indonesia and Pakistan) accounted for more than 80% of estimated cases
  • Two countries (India and Thailand) are on track to achieve a decrease of 50–75% in case incidence by 2015.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s